Enron Mail

From: brown_mary_jo@lilly.com To: Subject: **PRESS RELEASE**New Data Shows That Lilly Oncology's Anti-Cancer Cc: Bcc: Date: Tue, 23 Oct 2001 10:16:22 -0700 (PDT) Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-From: BROWN_MARY_JO@LILLY.COM@ENRON X-To: alfred.gilman@utsouthwestern.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, Lay, Kenneth </O=ENRON/OU=NA/CN=RECIPIENTS/CN=KLAY<, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu, win.bischoff@ssmb.com X-cc: X-bcc: X-Folder: \KLAY (Non-Privileged)\Lay, Kenneth\Inbox X-Origin: Lay-K X-FileName: KLAY (Non-Privileged).pst The attached press release was sent over Business Wire at 7:00 a.m. (ET) today. - Alimta-Pleural Mesothelioma release.doc